155 related articles for article (PubMed ID: 10516640)
1. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Langenegger D; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1999 Oct; 128(3):613-20. PubMed ID: 10516640
[TBL] [Abstract][Full Text] [Related]
2. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
[TBL] [Abstract][Full Text] [Related]
3. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
4. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
Gazi L; Schoeffter P; Nunn C; Croskery K; Hoyer D; Feuerbach D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
[TBL] [Abstract][Full Text] [Related]
5. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
Kula NS; Tarazi FI; Baldessarini RJ; Xu L; Bakthavachalam V; Pounds S; True CD
Eur J Pharmacol; 1999 Feb; 367(1):139-42. PubMed ID: 10082277
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
Kung MP; Stevenson DA; Zhuang ZP; Vessotskie JM; Chumpradit S; Sun XM; Kung HF
Life Sci; 1997; 60(2):91-100. PubMed ID: 9000114
[TBL] [Abstract][Full Text] [Related]
7. Binding of [3H]U-101958 to sigma1 receptor-like sites in human cerebellum and neuroblastoma cells.
Helmeste DM; Shioiri T; Mitsuhashi M; Tang SW
Eur J Pharmacol; 1999 Apr; 370(2):205-9. PubMed ID: 10323271
[TBL] [Abstract][Full Text] [Related]
8. Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor.
Schlachter SK; Poel TJ; Lawson CF; Dinh DM; Lajiness ME; Romero AG; Rees SA; Duncan JN; Smith MW
Eur J Pharmacol; 1997 Mar; 322(2-3):283-6. PubMed ID: 9098699
[TBL] [Abstract][Full Text] [Related]
9. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI
J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380
[TBL] [Abstract][Full Text] [Related]
10. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
Asghari V; Sanyal S; Buchwaldt S; Paterson A; Jovanovic V; Van Tol HH
J Neurochem; 1995 Sep; 65(3):1157-65. PubMed ID: 7643093
[TBL] [Abstract][Full Text] [Related]
11. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
[TBL] [Abstract][Full Text] [Related]
12. D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.
Chio CL; Drong RF; Riley DT; Gill GS; Slightom JL; Huff RM
J Biol Chem; 1994 Apr; 269(16):11813-9. PubMed ID: 7512953
[TBL] [Abstract][Full Text] [Related]
13. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
Newman-Tancredi A; Cussac D; Audinot V; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754
[TBL] [Abstract][Full Text] [Related]
14. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
15. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors.
Newman-Tancredi A; Audinot-Bouchez V; Gobert A; Millan MJ
Eur J Pharmacol; 1997 Jan; 319(2-3):379-83. PubMed ID: 9042615
[TBL] [Abstract][Full Text] [Related]
16. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the ligand binding and signaling properties of human dopamine D(2) and D(3) receptors in Chinese hamster ovary cells.
Vanhauwe JF; Fraeyman N; Francken BJ; Luyten WH; Leysen JE
J Pharmacol Exp Ther; 1999 Aug; 290(2):908-16. PubMed ID: 10411608
[TBL] [Abstract][Full Text] [Related]
18. Agonist activity of naloxone benzoylhydrazone at recombinant and native opioid receptors.
Olianas MC; Concas D; Onali P
Br J Pharmacol; 2006 Feb; 147(4):360-70. PubMed ID: 16402046
[TBL] [Abstract][Full Text] [Related]
19. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
Hall DA; Strange PG
Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
[TBL] [Abstract][Full Text] [Related]
20. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
